{"DataElement":{"publicId":"3762278","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Clinical T Stage","preferredDefinition":"Code to represent the post-neoadjuvant clinical T (tumor) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 7th Ed.","longName":"2663806v1.0:3762277v1.0","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"2663806","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy Clinical T Stage","preferredDefinition":"information related to post-neoadjuvant therapy clinical T stage for a breast tumor, the extent of maiignant breast neoplasm  involvement at the primary site (T, followed by a number indicating size and depth of invasion) based on clinical observation using the TMN staging system following treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"BRST_TUM_P_NEOAD_C_T","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2663804","version":"1","preferredName":"Post Neoadjuvant Therapy Clinical T Stage","preferredDefinition":"Post; occuring after.:Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C38008:C15665:C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FDEF88-8FA6-451B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"ONEDATA","dateModified":"2007-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FDEF88-8FB7-451B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3762277","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Clinical T Stage","preferredDefinition":"the post-neoadjuvant clinical T (tumor) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 7th Ed.","longName":"3762277v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"ycT0","valueDescription":"No evidence of primary tumor","ValueMeaning":{"publicId":"2559524","version":"1","preferredName":"No evidence of primary tumor","longName":"2559524","preferredDefinition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pT0 TNM Finding v6 and v7","conceptCode":"C60966","definition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B591-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AA6E-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT1","valueDescription":"TUMOR 2 CM OR LESS IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560324","version":"1","preferredName":"TUMOR 2 CM OR LESS IN GREATEST DIMENSION","longName":"2560324","preferredDefinition":"TUMOR 2 CM OR LESS IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AA83-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT1a","valueDescription":"TUMOR MORE THAN 0.1 CM BUT NOT MORE THAN 0.5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560356","version":"1","preferredName":"TUMOR MORE THAN 0.1 CM BUT NOT MORE THAN 0.5 CM IN GREATEST DIMENSION","longName":"2560356","preferredDefinition":"TUMOR MORE THAN 0.1 CM BUT NOT MORE THAN 0.5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AA98-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT1b","valueDescription":"TUMOR MORE THAN 0.5 CM BUT NOT MORE THAN 1 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2571751","version":"1","preferredName":"TUMOR MORE THAN 0.5 CM BUT NOT MORE THAN 1 CM IN GREATEST DIMENSION","longName":"2571751v1.00","preferredDefinition":"TUMOR MORE THAN 0.5 CM BUT NOT MORE THAN 1 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E554-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"MMADDINENI","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AAAD-C681-E040-BB89AD431BA5","beginDate":"2004-08-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT1c","valueDescription":"TUMOR MORE THAN 1 CM BUT NOT MORE THAN 2 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560358","version":"1","preferredName":"TUMOR MORE THAN 1 CM BUT NOT MORE THAN 2 CM IN GREATEST DIMENSION","longName":"2560358","preferredDefinition":"TUMOR MORE THAN 1 CM BUT NOT MORE THAN 2 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AAC2-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT2","valueDescription":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560359","version":"1","preferredName":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","longName":"2560359","preferredDefinition":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AAD7-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT3","valueDescription":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560360","version":"1","preferredName":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","longName":"2560360","preferredDefinition":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AAEC-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT4","valueDescription":"TUMOR OF ANY SIZE WITH DIRECT EXTENSION TO THE CHEST WALL AND/OR SKIN","ValueMeaning":{"publicId":"2560367","version":"1","preferredName":"TUMOR OF ANY SIZE WITH DIRECT EXTENSION TO THE CHEST WALL AND/OR SKIN","longName":"2560367","preferredDefinition":"TUMOR OF ANY SIZE WITH DIRECT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8DC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AB01-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT4a","valueDescription":"EXTENSION TO CHEST WALL","ValueMeaning":{"publicId":"2558757","version":"1","preferredName":"EXTENSION TO CHEST WALL","longName":"2558757","preferredDefinition":"EXTENSION TO CHEST WALL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B292-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AB16-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT4b","valueDescription":"EDEMA (INCLUDING PEAU D'ORANGE) OR ULCERATION OF THE SKIN OF THE BREAST OR SATELLITE SKIN NODULES CONFINED TO THE SAME BREAST","ValueMeaning":{"publicId":"2558711","version":"1","preferredName":"EDEMA (INCLUDING PEAU D'ORANGE) OR ULCERATION OF THE SKIN OF THE BREAST OR SATELLITE SKIN NODULES CONFINED TO THE SAME BREAST","longName":"2558711","preferredDefinition":"EDEMA (INCLUDING PEAU D'ORANGE) OR ULCERATION OF THE SKIN OF THE BREAST OR SATELLITE SKIN NODULES CONFINED TO THE SAME BREAST","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B264-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AB2B-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT4c","valueDescription":"BOTH T4A AND T4B","ValueMeaning":{"publicId":"2558324","version":"1","preferredName":"BOTH T4A AND T4B","longName":"2558324","preferredDefinition":"BOTH T4A AND T4B","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0E1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AB40-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycT4d","valueDescription":"Inflammatory Breast Carcinoma","ValueMeaning":{"publicId":"2558969","version":"1","preferredName":"Inflammatory Breast Carcinoma","longName":"2558969","preferredDefinition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Inflammatory Carcinoma","conceptCode":"C4001","definition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B366-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"TAYLORT","dateModified":"2017-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AB55-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"},{"value":"ycTX","valueDescription":"PRIMARY TUMOR CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559890","version":"1","preferredName":"PRIMARY TUMOR CANNOT BE ASSESSED","longName":"2559890","preferredDefinition":"PRIMARY TUMOR CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6FF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCC36551-AB69-C681-E040-BB89AD431BA5","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"ONEDATA","dateModified":"2013-05-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCC36551-AA4D-C681-E040-BB89AD431BA5","latestVersionIndicator":"Yes","beginDate":"2013-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"TAYLORT","dateModified":"2017-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"}]},{"publicId":"3886755","version":"1","longName":"Preoperative Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902140","version":"1","longName":"Preoperative","context":"BOLD"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Neoadjuvant Clinical T stage","type":"Preferred Question Text","description":"Neoadjuvant Clinical T stage","url":null,"context":"NCIP"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DCC3965C-A991-95E9-E040-BB89AD434E1A","latestVersionIndicator":"Yes","beginDate":"2013-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"REEVESD","dateModified":"2016-09-06","changeDescription":"Curated to support Breast Oncology Local Disease (BOLD) Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}